Swiss stocks - Factors to watch on Aug 9

MindMaze Therapeutics Holding SA

09/08/2021 06:25

ZURICH/BERLIN, Aug 9 (Reuters) - Here are some of the main
factors that may affect Swiss stocks on Monday:
    
      
    COMPANY STATEMENTS
    * Roche  ROG.S  said its Polivy drug met the primary
endpoint of progression-free survival in a trial.  ROG.S 
    * Sika  SIKA.S  said it had acquired Bexel Internacional
S.A., a manufacturer of tile adhesives and stuccos in Mexico.
 SIKA.S 
    * Relief Therapeutics  RLFB.S  announced with Acer
Therapeutics sumbitting a new drug application to the U.S. FDA
for Acer-001 for treatment of urea cycle disorders.  RLFB.S 
    

    ECONOMY
    Swiss July Unemployment Rate due at 0545 GMT. Seen 2.8%
adjusted, 3.0% unadjusted. 
    SNB Sight Deposits due at 0800 GMT.

 (Reporting by Zurich newsroom and Berlin Speed Desk)
 ((+41 58 306 7336; zurich.newsroom@thomsonreuters.com))
 
((For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g
FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German  .SDE 
All SMI constituent stocks  0#.SSMI 
DJ STOXX index  .STOXX 
Top 10 STOXX sectors  .PGL.STOXXS 
Top 10 EUROSTOXX sectors  .PGL.STOXXES 
Swiss mid-cap index  .SSMI 
Swiss all-share index  .SSHI 
Swiss market digest  .AD.S 
Sector overview  CH/SECTOR1 
All Swiss news  CH 
Swiss research news  CH-RCH   
All equity news  E 
SPEED GUIDES:   EQUITY   EQUITY/NEWS1   EUR/EQUITY   SWITZERLAND   REUTERS  ))